Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin in Combination With Standard Antimicrobial Treatment of Pulmonary Tuberculosis in People Co-infected With HIV
NCT04930744Phase 2Completed
- Sponsor
- University of Massachusetts
- Start
- Mar 2022
- Primary completion
- Apr 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of liquid metformin (Aspargo Labs) in Tuberculosis (TB), sponsored by University of Massachusetts. Started Mar 2022; status: completed.
02
Drugs
liquid metformin (Aspargo Labs)
03
Conditions
Tuberculosis (TB)
Beyond the preview
Go deeper on NCT04930744.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04930744.